Targeting HER2, BRAF, KRAS, MET, TRK

Targeting HER2, BRAF, KRAS, MET, TRK

Potential and progress in targeting less common markers: HER2, BRAF, KRAS, MET, TRK, and RETПодробнее

Potential and progress in targeting less common markers: HER2, BRAF, KRAS, MET, TRK, and RET

Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - NoПодробнее

Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhDПодробнее

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD

BRAF Mutations in Colorectal CancerПодробнее

BRAF Mutations in Colorectal Cancer

KRAS, BRAF and RAS Webinar | Fight Colorectal CancerПодробнее

KRAS, BRAF and RAS Webinar | Fight Colorectal Cancer

Targeting HER2, BRAF, KRAS, METПодробнее

Targeting HER2, BRAF, KRAS, MET

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunitiesПодробнее

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

HER-2/BRAF/KRAS and METПодробнее

HER-2/BRAF/KRAS and MET

Targeting HER2 in Colorectal CancerПодробнее

Targeting HER2 in Colorectal Cancer

AC21 - Ardaman Shergill: MAPK Pathway Targeting in CholangiocarcinomaПодробнее

AC21 - Ardaman Shergill: MAPK Pathway Targeting in Cholangiocarcinoma

Panel Discussion Targeting KRASПодробнее

Panel Discussion Targeting KRAS

Case 3: KRAS-Mutated Metastatic Colon CancerПодробнее

Case 3: KRAS-Mutated Metastatic Colon Cancer

GRACE Targeted Therapies Lung Cancer 2021 - New Therapies: NTRK, RET and HER2Подробнее

GRACE Targeted Therapies Lung Cancer 2021 - New Therapies: NTRK, RET and HER2

Frontline Treatment for KRAS Wild-Type mCRCПодробнее

Frontline Treatment for KRAS Wild-Type mCRC

Dr. Desai on BGB-283 in Patients With BRAF or KRAS/NRAS Solid TumorsПодробнее

Dr. Desai on BGB-283 in Patients With BRAF or KRAS/NRAS Solid Tumors

HER2 Targeted Therapy for Treatment of NSCLCПодробнее

HER2 Targeted Therapy for Treatment of NSCLC

Novel therapies beyond immunotherapy for GI MalignanciesПодробнее

Novel therapies beyond immunotherapy for GI Malignancies